Structured Summary
Abstract
A ganciclovir prodrug and antiviral agent that is used to treat CYTOMEGALOVIRUS RETINITIS in patients with AIDS, and for the prevention of CYTOMEGALOVIRUS INFECTIONS in organ transplant recipients who have received an organ from a CMV-positive donor.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
5 entry terms
- Ganciclovir L-valyl Ester
- Ganciclovir L valyl Ester
- Valcyt
- Valcyte
- Valganciclovir Hydrochloride
MeSH Record
Aspects Covered
25 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2019 (1999)
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Valganciclovir. Medical Subject Headings (MeSH). 2026. Unique ID D000077562. http://id.nlm.nih.gov/mesh/2026/D000077562
- Valganciclovir. In: Wikipedia. https://en.wikipedia.org/wiki/Valganciclovir
- Valganciclovir. In: Wikidata. https://www.wikidata.org/wiki/Q423384